Metagenomic gut microbiome analysis of Japanese patients with multiple chemical sensitivity/idiopathic environmental intolerance/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2025-2-27

Curated date: 2025/02/13

Curator: Taofeecoh

Revision editor(s): WikiWorks, Taofeecoh

Subjects

Location of subjects
Japan
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Multiple chemical sensitivity 20th century disease,chemical AIDS,environmental illness,idiopathic environmental illness,Multiple Chemical Sensitivity,multiple chemical sensitivity,total allergy syndrome,Multiple chemical sensitivity
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control (HC)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Multiple Chemical Sensitivity (MCS)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Japanese female patients with Multiple Chemical Sensitivity (MCS)
Group 0 sample size Number of subjects in the control (unexposed) group
24
Group 1 sample size Number of subjects in the case (exposed) group
30
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-2-27

Curated date: 2025/02/13

Curator: Taofeecoh

Revision editor(s): Taofeecoh, WikiWorks

Source: Fig. 2b, Fig. 3a, Fig. 4a, Additional File Fig. S1a

Description: Relative abundances of species that differed significantly between multiple chemical sensitivity (MCS, n = 30) patients and healthy controls (HC, n = 24).

Abundance in Group 1: increased abundance in Multiple Chemical Sensitivity (MCS)

NCBI Quality ControlLinks
Actinomyces
Akkermansia
Akkermansia muciniphila
Akkermansia sp. CAG:344
Bacteroides fragilis str. 3976T8
Bifidobacterium animalis subsp. animalis
Blautia obeum A2-162
Clostridium sp. CAG:217
Clostridium sp. CAG:264
Clostridium sp. CAG:273
Clostridium sp. CAG:352
Dialister
Dialister invisus DSM 15470
Dialister sp. CAG:357
Enterococcus durans ATCC 6056
Eubacterium sp. CAG:192
Eubacterium sp. CAG:202
Eubacterium sp. CAG:251
Lactobacillus
Lactobacillus delbrueckii subsp. jakobsenii ZN7a-9 = DSM 26046
Phocaeicola dorei CL02T12C06
Roseburia intestinalis M50/1
Ruminococcus bromii L2-63
Ruminococcus sp. CAG:177
Ruminococcus sp. CAG:254
Ruminococcus sp. CAG:57
Ruminococcus sp. JC304
Streptococcus
Streptococcus lutetiensis 033
Streptococcus parasanguinis
Streptococcus salivarius
Streptococcus sp. C150
Streptococcus sp. HSISS1
Streptococcus thermophilus TH985
Streptococcus vestibularis ATCC 49124
Thomasclavelia
Thomasclavelia ramosa DSM 1402
Veillonella
Veillonella sp. CAG:933
Verrucomicrobiota

Revision editor(s): Taofeecoh, WikiWorks

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-2-27

Curated date: 2025/02/13

Curator: Taofeecoh

Revision editor(s): Taofeecoh, WikiWorks

Source: Fig. 2a, Fig. 3b, Fig. 4b, Additional File Fig. S1b

Description: Relative abundances of species that differed significantly between multiple chemical sensitivity (MCS, n = 30) patients and healthy controls (HC, n = 24).

Abundance in Group 1: decreased abundance in Multiple Chemical Sensitivity (MCS)

NCBI Quality ControlLinks
Actinomycetota
Blautia sp. CAG:37
Clostridium sp. CAG:127
Clostridium sp. CAG:138
Dialister sp. CAG:486
Faecalibacterium duncaniae
Hungatella hathewayi 12489931
Megamonas
Megamonas hypermegale ART12/1
Megamonas rupellensis DSM 19944
Roseburia hominis A2-183
Clostridiales bacterium VE202-27
Mitsuokella multacida DSM 20544
unclassified Erysipelotrichaceae
Phascolarctobacterium succinatutens YIT 12067

Revision editor(s): Taofeecoh, WikiWorks